Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Köppel A, Tolosa E, Hoberg M, Anderl J, Aicher WK, Weller M, Wick W, Platten M. Opitz CA, et al. Among authors: anderl j. Stem Cells. 2009 Apr;27(4):909-19. doi: 10.1002/stem.7. Stem Cells. 2009. PMID: 19353519
Antibody-drug conjugate payloads.
Anderl J, Faulstich H, Hechler T, Kulke M. Anderl J, et al. Methods Mol Biol. 2013;1045:51-70. doi: 10.1007/978-1-62703-541-5_4. Methods Mol Biol. 2013. PMID: 23913141 Review.
TP53 loss creates therapeutic vulnerability in colorectal cancer.
Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Rao PH, Maru DM, Pahl A, He X, Sood AK, Ellis LM, Anderl J, Lu X. Liu Y, et al. Among authors: anderl j. Nature. 2015 Apr 30;520(7549):697-701. doi: 10.1038/nature14418. Epub 2015 Apr 22. Nature. 2015. PMID: 25901683 Free PMC article.
Antibody-drug conjugates: What drives their progress?
Pander G, Uhl P, Kühl N, Haberkorn U, Anderl J, Mier W. Pander G, et al. Among authors: anderl j. Drug Discov Today. 2022 Oct;27(10):103311. doi: 10.1016/j.drudis.2022.06.011. Epub 2022 Jul 3. Drug Discov Today. 2022. PMID: 35787480 Review.
Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer.
Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Rao PH, Maru DM, Pahl A, He X, Sood AK, Ellis LM, Anderl J, Lu X. Liu Y, et al. Among authors: anderl j. Nature. 2021 Sep;597(7875):E6. doi: 10.1038/s41586-021-03664-3. Nature. 2021. PMID: 34433970 No abstract available.
34 results